Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor|Cholangiocarcinoma|HER2-negative Breast Cancer|Triple Negative Breast Cancer|Bladder Cancer|Small-cell Lung Cancer|Prostate Cancer|Thyroid Cancer|Sarcoma|Gastric Cancer|Gallbladder Cancer
Interventions: DRUG: TT-00420|COMBINATION_PRODUCT: Nab-Paclitaxel
Sponsor: TransThera Sciences (Nanjing), Inc.